China Earmarks RMB 300 Million For H7N9 Flu Monitoring
This article was originally published in PharmAsia News
Executive Summary
The Chinese government recently earmarked over RMB 300 million ($48 million) for monitoring of influenza and new types of pneumonia, particularly H7N9 flu and severe acute respiratory syndromes.